FDA Drug Recalls

Recalls / Class II

Class IID-1098-2014

Product

Lidocaine 4% Urethral Gel

Affected lot / code info
Lot# 101213, Exp. 04/14 Lot# 09202013, Exp. 03/14 Lot# 08272013, Exp. 02/14 Lot# 08022013, Exp. 01/14

Why it was recalled

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Recalling firm

Firm
Natures Pharmacy & Compounding Center
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
752 Biltmore Ave, Asheville, North Carolina 28803-2558

Distribution

Quantity
104 syringes
Distribution pattern
NC

Timeline

Recall initiated
2013-11-01
FDA classified
2014-03-04
Posted by FDA
2014-03-12
Terminated
2014-04-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1098-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls